J&J readies Mylanta acid blocker

Published on .

Looking to go head-to-head with the explosion in acid blockers, Johnson & Johnson/Merck is creating a Mylanta extension, Mylanta AR, the fifth blocker into the $1.5 billion stomach remedies market. Saatchi & Saatchi Advertising's Healthcare Connection, New York, handles the third-ranked brand, supported by $36 million in 1995, but still slipping in sales.

Copyright December 1996, Crain Communications Inc.

Most Popular
In this article: